Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,162 | 23 | 96.0% |
| Education | $89.24 | 2 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $566.95 | 6 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $458.45 | 4 | $0 (2018) |
| Amgen Inc. | $359.37 | 3 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $205.17 | 2 | $0 (2019) |
| Cook Incorporated | $149.69 | 2 | $0 (2017) |
| Cook Medical LLC | $144.07 | 2 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $138.04 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $117.53 | 2 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $82.99 | 1 | $0 (2019) |
| Alcon Laboratories Inc | $28.72 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $602.37 | 7 | Cook Medical LLC ($144.07) |
| 2018 | $576.02 | 7 | Amgen Inc. ($240.85) |
| 2017 | $1,073 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($352.35) |
All Payment Transactions
25 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $119.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $123.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/28/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: VACCINE | ||||||
| 05/07/2019 | Cook Medical LLC | Cook Medical AAA (Device) | Food and Beverage | Cash or cash equivalent | $91.98 | General |
| Category: Aortic Intervention | ||||||
| 04/08/2019 | Cook Medical LLC | Cook Medical Introducers (Device) | Food and Beverage | Cash or cash equivalent | $52.09 | General |
| Category: Peripheral Intervention | ||||||
| 04/02/2019 | AstraZeneca Pharmaceuticals LP | — | Education | In-kind items and services | $82.99 | General |
| 01/14/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $118.52 | General |
| Category: Cardiology | ||||||
| 11/29/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $81.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/11/2018 | Alcon Laboratories Inc | DAILIES (Device) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Ophthalmology | ||||||
| 06/05/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/14/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $106.10 | General |
| Category: DIABETES | ||||||
| 04/03/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $116.21 | General |
| Category: Cardiology | ||||||
| 02/07/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $115.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/11/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.64 | General |
| Category: Cardiology | ||||||
| 10/19/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug) | Food and Beverage | In-kind items and services | $111.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/02/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $117.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/22/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $110.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2017 | Merck Sharp & Dohme Corporation | GARDASIL (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: VACCINE | ||||||
| 05/16/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.58 | General |
| Category: DIABETES | ||||||
| 04/26/2017 | Cook Incorporated | Cook Medical Thoracic (Device) | Food and Beverage | Cash or cash equivalent | $72.24 | General |
| Category: Aortic Intervention | ||||||
| 04/10/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Education | Cash or cash equivalent | $6.25 | General |
| Category: Cardiovascular | ||||||
| 04/03/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $100.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/08/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $111.28 | General |
| Category: Cardiovascular | ||||||
| 03/07/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $120.84 | General |
| Category: DIABETES | ||||||
| 02/16/2017 | Cook Incorporated | Cook Medical Thoracic (Device) | Food and Beverage | Cash or cash equivalent | $77.45 | General |
| Category: Aortic Intervention | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,312 | 3,581 | $360,720 | $78,346 |
| 2022 | 12 | 1,940 | 2,612 | $146,865 | $45,801 |
| 2021 | 9 | 1,771 | 2,405 | $112,836 | $37,280 |
| 2020 | 23 | 1,557 | 1,934 | $174,420 | $47,893 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 320 | 361 | $95,994 | $19,501 | 20.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,264 | 2,387 | $56,751 | $15,300 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 86 | $46,882 | $9,180 | 19.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $47,336 | $8,345 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 73 | $28,195 | $5,558 | 19.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 44 | 44 | $12,832 | $4,416 | 34.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 23 | $17,559 | $3,536 | 20.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 40 | 54 | $8,870 | $3,536 | 39.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 33 | 50 | $5,031 | $1,962 | 39.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 124 | 156 | $14,634 | $1,949 | 13.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 84 | 87 | $6,345 | $1,392 | 21.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 84 | 87 | $7,998 | $925.62 | 11.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 21 | $3,738 | $884.99 | 23.7% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 13 | 14 | $3,796 | $815.38 | 21.5% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Facility | 2023 | 22 | 26 | $2,401 | $563.70 | 23.5% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 13 | 14 | $1,265 | $257.74 | 20.4% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 11 | 11 | $534.00 | $108.46 | 20.3% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 13 | 13 | $381.00 | $79.30 | 20.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 13 | 13 | $178.00 | $34.19 | 19.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 315 | 328 | $61,892 | $18,365 | 29.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 1,234 | 1,861 | $39,322 | $12,188 | 31.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 33 | 43 | $7,377 | $3,407 | 46.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 27 | 28 | $7,355 | $3,065 | 41.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 53 | $9,441 | $2,780 | 29.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 107 | 107 | $5,992 | $1,877 | 31.3% |
About Dr. Daniel Lee, MD
Dr. Daniel Lee, MD is a Internal Medicine healthcare provider based in Dedham, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1023015609.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Lee, MD has received a total of $2,251 in payments from pharmaceutical and medical device companies, with $602.37 received in 2019. These payments were reported across 25 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,162).
As a Medicare-enrolled provider, Lee has provided services to 7,580 Medicare beneficiaries, totaling 10,532 services with total Medicare billing of $209,320. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Dedham, MA
- Active Since 06/28/2005
- Last Updated 08/05/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1023015609
Products in Payments
- ENTRESTO (Drug) $566.95
- Repatha (Biological) $359.37
- JARDIANCE (Drug) $346.52
- XARELTO (Drug) $205.17
- Cook Medical Thoracic (Device) $149.69
- GARDASIL (Biological) $125.00
- ELIQUIS (Drug) $117.53
- PRADAXA (Drug) $111.93
- Cook Medical AAA (Device) $91.98
- Cook Medical Introducers (Device) $52.09
- DAILIES (Device) $28.72
- PNEUMOVAX 23 (Biological) $13.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dedham
Agostino Iarrobino, Do, DO
Internal Medicine — Payments: $18,343
Claes Nilsson, Md, MD
Internal Medicine — Payments: $1,279
Shahab Mohiuddin, M.d, M.D
Internal Medicine — Payments: $1,121
Dr. Erica Frank, M.d. M.p.h, M.D. M.P.H
Internal Medicine — Payments: $1,066
David Blom, Md, MD
Internal Medicine — Payments: $566.00
Irene Goranitis, M.d, M.D
Internal Medicine — Payments: $342.94